Krishna Institute of Medical Sciences Limited (KIMS) has made a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding an upcoming conference call with analysts and investors.
The company will participate in a conference call hosted by IIFL Capital on Thursday, 5th November 2026 at 10:00 am IST to discuss the company's business strategy and outlook following the declaration of Q2FY27 financial results.
Management Participants
- Dr. Bhaskara Rao Bollineni - Founder & Managing Director
- Dr. Abhinay Bollineni - Executive Director and CEO
- Mr. Sachin Salvi - Chief Financial Officer
Conference Call Details
- Date: Thursday, 5th November 2026
- Time: 10:00 am IST
- Host: IIFL Capital
Dial-in Numbers
Universal Access (India): +91 22 6280 1259 / +91 22 7115 8160
International Toll-free numbers:
- USA: 1-866 746 2133
- UK: 0-808 101 1573
- Singapore: 800-101 2045
- Hong Kong: 800-964 448
IIFL Capital Contacts
- Rahul Jeewani: +91 22 4646 4673, rahul.jeewani@iiflcap.com
- Naman Bagrecha: +91 22 4646 4718, naman.bagrecha@iiflcap.com
- Aman Goyal: +91 22 4646 4705, aman.goyal@iiflcap.com
- Vighnesh Indure: +91 22 4646 4661, vighnesh.indure@iiflcap.com
The disclosure was signed by Nagajayanthi J R, Company Secretary & Compliance Officer, and digitally signed on 29th October 2026 at 18:41:10 IST.